Loading organizations...
§ Private Profile · Spokane, WA, USA
PathFlow digital pathology software for healthcare labs. Cloud-based platform streamlines workflows for disease diagnosis.
Based in Spokane, Washington, Gestalt Diagnostics develops PathFlow, a cloud-based software platform that digitizes workflows for pathologists and pathology laboratories. The private enterprise operates with nearly twenty employees across additional offices in Boise, San Jose, and Boston, having secured seven and a half million dollars in Series A funding to expand its integrated artificial intelligence capabilities. Originally adapted from radiology software utilized in over thirteen million annual hospital studies, the platform replaces traditional microscopes and manual paper processes for disease diagnosis. Gestalt Diagnostics serves clinical healthcare facilities across more than thirty-five states, Puerto Rico, and the United States Virgin Islands, expanding its professional laboratory integration services through the 2019 acquisition of Peak Medical Technologies. Founder and chief executive officer Dan Roark currently leads the organization alongside chief operating officer Lisa-Jean Clifford to drive triple-digit revenue growth.
Gestalt Diagnostics has raised $7.5M across 1 funding round.
Gestalt Diagnostics has raised $7.5M in total across 1 funding round.
Gestalt Diagnostics has raised $7.5M across 1 funding round. Most recently, it raised $7.5M Series A in April 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Apr 28, 2025 | $7.5M Series A | Cowles Company, Inland Imaging Investments, Kickstart Seed Fund, Techvision Fund | — | Announced |
Gestalt Diagnostics has raised $7.5M in total across 1 funding round.
Gestalt Diagnostics's investors include Cowles Company, Inland Imaging Investments, Kickstart Seed Fund, TechVision Fund.